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Sequences at the beginnings and ends of Human respiratory syncytial virus (HRSV) genes are necessary for efficient initiation and
termination of transcription. The gene start sequences are well conserved and contain signals required for initiation, while the semi-conserved
sequences at the gene ends direct transcriptional termination with varying efficiencies. The intergenic regions, which lie between the gene
ends and the downstream gene start sequences, are not conserved in length or sequence, and certain positions have been reported to play a
role in transcriptional regulation. We have previously shown that the gene end sequences in HRSV subgroup A clinical isolates are variable
and that variations found at certain gene ends decreased transcriptional termination and downstream mRNA expression. Here, we have
extended this work to examine variation in the intergenic regions between the genes of clinical isolates. We determined the sequences of the
eight intergenic regions and the M2/L overlap from clinical isolates from the US and UK and found that all of these regions contained
variations from the prototype A2 strain. The amount of variation observed was disparate among the different intergenic regions and did not
correlate with length. The effects of selected variant sequences on transcription were examined in the context of subgenomic replicons. While
some changes in the intergenic regions had minor effects, certain sequence variations significantly altered transcription termination or
initiation. A single nucleotide deletion in the M/SH intergenic region decreased initiation at the SH gene start seven-fold, while changes in the
F/M2 intergenic region were found that in some cases increased and in others decreased termination at the F gene end. The P/M intergenic
region was the most variable, but none of the changes examined affected either termination at the P gene end or initiation of the downstream
M gene start. These results show that in HRSV clinical isolates the intergenic region sequences are variable and that changes in these regions
have the potential to affect transcriptional control at the gene junctions.
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Introduction 1999; Harmon et al., 2001; Kuo et al., 1996b, 1997). AtHuman respiratory syncytial virus (HRSV) is the lead-
ing viral cause of pediatric pneumonia and bronchiolitis
(Hall, 1999; Hall and McCarthy, 2000). A member of the
Paramyxoviridae family, HRSV has a nonsegmented, neg-
ative-sense (NNS) RNA genome containing ten genes that
encode 11 known viral proteins (Collins and Wertz, 1983;
Collins et al., 1984). Transcription of the HRSV genome
proceeds sequentially from a single 3V promoter, and
termination of each upstream gene is required for initiation
of the downstream gene (Dickens et al., 1984; Hardy et al.,0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: gailw@uab.edu (G.W. Wertz).each gene junction, there is transcriptional attenuation,
such that the level of viral gene expression is primarily
controlled by the position of a gene relative to the 3V end
of the genome (Dickens et al., 1984; Pringle and Easton,
1997).
HRSV genes contain conserved sequences at their
starts and partially conserved sequences at their ends.
The non-transcribed regions between the genes vary in
both length and sequence and are called the intergenic
regions (Collins et al., 1986). The gene junction collec-
tively describes the gene end sequence of an upstream
gene, the intergenic region, and the gene start sequence of
a downstream gene. This region contains elements re-
quired for efficient termination of transcription of the
upstream gene and transcriptional initiation of the down-
stream gene (Harmon and Wertz, 2002; Harmon et al.,
Table 1
Location and year of isolation and genotype of clinical isolates
Virus Location isolated
(year)
Genotypea Isolate
code
A2 Australia (1961) – A2
AL-180893 USA (1994) GA5 1
AL-180081 USA (1994) GA5 2
AL-203721 USA (1995) GA5 3
AL-205342 USA (1995) GA3 4
AL-195131 USA (1995) GA1 5
AL194465 USA (1994) GA1 6
RSB89-1734 UK (1989) GA1 7
RSB89-6614 UK (1989) GA3 8
RSB89-6190 UK (1989) GA5 9
RSB89-6256 UK (1989) GA3 10
RSB89-5857 UK (1989) GA3 11
RSB90-8106 UK (1990) GA2 12
RSG1503 UK (1972) GA1 13
RSS2 UK (1976) GA5 14
a Italics indicate that the isolate clusters near, but not with, others of the
stated genotype.
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(3V...CCCc/uGUUUa/uA...5V) are required for efficient
initiation of downstream gene transcription (Kuo et al.,
1996b, 1997). Sequences at the ends of the genes
(3V...UCAAUN1–4U4–7...5V) are necessary for efficient
transcriptional termination (Cartee et al., 2003; Harmon
et al., 2001; Kuo et al., 1996b, 1997; Sutherland et al.,
2001). The efficiency of termination at the HRSV gene
junctions varies. Some, such as the SH/G junction,
terminate highly efficiently, while others, such as the
NS1/NS2 and NS2/N junctions, terminate substantially
less well and produce large amounts of polycistronic
messages, or readthrough mRNAs, resulting from the
failure to terminate at the upstream gene end sequence
(Cartee et al., 2003; Hardy et al., 1999; Kuo et al., 1997).
The serogroup A HRSV intergenic regions range from
one (N/P) to 52 (G/F) nucleotides in length. They have
little discernable sequence conservation, although all end
with an A and, with the exception of the P/M intergenic
region, all are A/U-rich. Previous studies have found that
the first and last nucleotide of the HRSV intergenic regions
can affect termination and initiation, respectively (Harmon
and Wertz, 2002; Kuo et al., 1996a, 1997). When the first
nucleotide of the intergenic region was an A rather than a
G or C, termination was decreased if the upstream gene
end sequence contained a U4-tract (Harmon and Wertz,
2002). Kuo et al. (1997) found that changing the con-
served A at the end of the HRSV intergenic region
sequence inhibited initiation of the downstream gene. A
separate study suggested that the variable intergenic
regions did not appear to play a role in the transcriptional
gradient in HRSV, since replacing the N/P intergenic
region with all others did not greatly affect transcription
(Kuo et al., 1996a). However, this work did not examine
the interplay between the different gene ends and their
variant intergenic regions.
Previously, we examined the extent and effect of
variation in the gene start and end sequences of a group
of HRSV serogroup A clinical isolates (Moudy et al.,
2003). We found that while the gene start sequences did
not vary, the sequences at certain gene ends varied
substantially. Variation at the ends of two of the glycopro-
tein genes, SH and G, were shown to have significant
effects on the efficiency of transcriptional termination. In
the present study, we have extended this work to examine
whether HRSV clinical isolates contain variation in their
individual intergenic regions and, if so, whether it had an
effect on transcription. We determined the intergenic re-
gion sequences at each of the nine gene junctions of 14
subgroup A HRSV isolates from the United States of
America (USA) and the United Kingdom (UK). The
intergenic regions were found to vary in sequence; how-
ever, the extent of variation was different for each inter-
genic region and did not correspond with the length of the
sequence. The effects of these changes on transcriptional
termination and initiation were examined.Results
Analysis of intergenic region sequences from HRSV clinical
isolates
We analyzed the sequences of the intergenic regions
between each of the HRSV genes from a group of 14
subgroup A clinical isolates: six from Children’s Hospital
in Birmingham, Alabama (AL-180893, AL-180081, AL-
203721, AL-205342, AL-195131, AL-194465) (Coggins et
al., 1998) and eight from the United Kingdom (RSB89-1734,
RSB89-6614, RSB89-6190, RSB89-6256, RSB89-5857,
RSB90-8106, RSG1503, RSS2) (Table 1) (Cane and Pringle,
1991, 1995; Tolley et al., 1996). The genotypes to which
these isolates belong have been previously described (Cane
and Pringle, 1995; Cane et al., 1994; Coggins et al., 1998;
Peret et al., 2000; Sullender, 2000; Tolley et al., 1996). No
additional intergenic sequences from subgroup A clinical
isolates were found in Genbank, therefore, the analysis was
limited to the sequences determined in this study.
Changes in sequence from that of the prototype A2
strain were found at each of the intergenic regions (Tables 2
and 3). Intergenic region sequences identical to the A2
sequence were found at the NS1/NS2 (one isolate), NS2/N
(two isolates), N/P (10 isolates), and M2/L (10 isolates)
gene junctions. At the other gene junctions, all the isolates’
intergenic region sequences varied from the A2 sequence
by at least one nucleotide. The longer intergenic regions
tended to have the highest number of unique sequences, but
this trend was not absolute, as both the M/SH intergenic
region (9 nt) and the SH/G intergenic region (44 nt) had 11
different sequences. In general, the isolate sequences were
more similar to each other than to A2 and isolates belong-
ing to a single genotype had intergenic regions that were
Table 2
Intergenic region sequences of clinical isolates: NS1/NS2 TO M/SH
a,*Identical nucleotide; -:gap in alignment.
bNumbers refer to the isolate code shown in Table 1.
cPercent identity to A2 calculated as the number of positions in the isolate sequence that are identical to the A2 sequence in the alignment divided by the total
number of nucleotide positions in the sequence alignment.
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to A2.
To further examine the amount of variability in each in-
tergenic region, we compared the sequence of each inter-
genic region of each isolate to that of the corresponding A2
intergenic sequence and calculated its percent identity to A2
(Tables 2 and 3). By this analysis, there was no correlation
between sequence variation and intergenic region length.
The average identity to A2 ranged from a low of 34.9%(P/M) to a high of 99.4% (M2/L overlap), with the
majority of the intergenic regions having an average of
75% to 90% identity to A2. Intergenic region sequences
from isolates with the genotype GA1 nearly always had
the highest identity to A2, while sequences from GA3 and
GA5 isolates generally had the lowest identity to A2
(Tables 2 and 3).
Previous work with HRSV intergenic regions has shown
that certain variations in these sequences can inhibit
Table 3
Intergenic region sequences of clinical isolates: SH/G to M2/La
aAll sequences are intergenic region sequences, except for M2/L, which is the sequence of the M2/L overlap.
bNumbers refer to the isolate code shown in Table 1.
cPercent identity to A2 calculated as the number of positions in the isolate sequence that are identical to the A2 sequence in the alignment divided by the total
number of nucleotide positions in the sequence alignment.
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et al., 1997). Harmon and Wertz (2002) have shown that
an intergenic region beginning with an A in combination
with a gene end U-tract of four nucleotides decreased
termination at that gene end by approximately 50%. It
has also been shown that changing the conserved A
immediately upstream of the gene start sequence to either
a C or U, but not a G, decreased initiation (Kuo et al.,
1997). However, to our knowledge, a study of the effects
of naturally occurring intergenic region variations on
transcription has not been performed. We selected several
gene junctions containing intergenic regions of various
lengths [N/P (1 nt), P/M (9 nt, G/C-rich), M/SH (9 nt,
A/U-rich), and F/M2 (44 nt)] and examined the effects of
variant sequences on transcription.Effect of a variant intergenic region sequence on
transcription at the N/P gene junction
The N/P gene junction has the shortest intergenic region
in HRSV, normally a single nucleotide. Out of the 14
isolates, 10 contained the A2 intergenic sequence
(3V. . .A. . .5V) at this gene junction, while the sequence
3V...CA...5Vwas found at the N/P intergenic regions of four
isolates (Table 2). To determine if this sequence affected
transcription at this gene junction, we replaced the inter-
genic region of the previously characterized HRSV sub-
genomic replicon containing the N/P gene junction
sequence from the prototype strain A2, pN/P, (Hardy et
al., 1999), with the dinucleotide sequence CA, creating
replicon pN/P-CA. The intergenic region sequences of
Fig. 1. Effect of the variant intergenic region CA on transcription at the N/P
gene junction. (A) Schematic of, and RNA species produced by, dicistronic
replicons pN/P and pN/P-CA. Each replicon contains 379 nucleotides
surrounding and including that N/P gene junction from the A2 strain of
HRSV. Replicon pN/P-CA has a single nucleotide insertion at the beginning
of the intergenic region. The relevant RNA species produced from these
replicons are shown: (1) replication product (rep.); (2) upstream mRNA
product (mRNA 1); (3) downstream mRNA product (mRNA 2); and (4)
upstream-downstream readthrough product (r/t 1–2). le: leader region; tr:
trailer region. HEp-2 cells were infected with MVA-T7, followed by
transfection with plasmids expressing the HRSV N, P, M2-1, and L proteins
and a plasmid encoding the replicon, all with T7 promoters. RNA products
synthesized from these templates were metabolically labeled with [3H]-
uridine, separated by electrophoresis on agarose-urea gels, and visualized by
fluorography. (B) Readthrough synthesis and termination efficiencies from
replicons pN/P and pN/P-CA. Readthrough synthesis and percent
termination were determined as described in Materials and methods. Shaded
bars represent the mean of at least three separate experiments, with error bars
indicating the standard deviations. Dotted line indicates the level of
readthrough associated with the A2 sequence. (C) Downstream initiation
efficiency of replicons pN/P and pN/P-CA. Initiation efficiency was
determined as described in Materials and methods. Shaded bars represent
the mean of at least three separate experiments, with error bars indicating the
standard deviations. Dotted line indicates the level of initiation associated
with the A2 sequence.
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in Fig. 1A.
RNA synthesis directed by the each of the replicons was
assayed in HEp-2 cells infected with MVA-T7, a recombi-nant vaccinia virus that expresses T7 RNA polymerase
(Wyatt et al., 1995). The cells were co-transfected with
plasmids encoding the N, P, L, and M2-1 proteins and a
plasmid expressing one of the subgenomic replicons de-
scribed in Materials and methods. The effects of alterations
in the intergenic regions on mRNA termination and initia-
tion in these and all following experiments were measured
by direct metabolic labeling of RNAs with [3H]-uridine,
followed by electrophoretic separation of the RNAs and
densitometric quantitation of fluorographed gels, as detailed
in Materials and methods. Briefly, termination was assayed
in two ways: (1) by calculating the percent termination, that
is, the amount of monocistronic message initiated at the first
gene start sequence and terminated at the first gene end
sequence (see formula in Materials and methods) or (2) by
measuring the failure to terminate as indicated by the
percentage of readthrough RNA products, that is, the
amount of message initiated at the first gene start sequence,
which, upon failure of the polymerase to terminate at the
first gene end, reads through the gene junction to terminate
at the second gene end yielding a dicistronic (readthrough)
RNA (see Materials and methods for formula). Initiation
was assayed by calculating the amount of monocistronic
message initiating at the second gene start and terminating at
the second gene end (see formula in Materials and methods).
At the N/P gene junction, the variant intergenic region
CA slightly decreased termination at the N gene end, as
measured by a 2.5-fold increase in readthrough mRNA
synthesis (Fig. 1B). However, initiation at the P gene start
remained nearly identical with either intergenic region (Fig.
1C). These data indicate that the CA variant intergenic
region had little effect on transcription, and that the
observed effect is mainly on termination, rather than
initiation.
Effect of five variant intergenic regions on transcription at
the P/M gene junction
The P/M intergenic region sequence of the prototype A2
strain is unusual among the HRSV intergenic regions in
that it is the only one that is not A/U-rich (only 44% A/U
compared to an average of 65% A/U in the other intergenic
regions). None of the clinical isolates sequenced contained
the A2 sequence at this intergenic region. The most
prevalent variant sequence found involved a deletion of
six out of the nine nucleotides present in the prototype
sequence (Table 2). To determine if these variant intergenic
region sequences affected termination at the P/M gene
junction, we replaced the A2 intergenic sequence in a
previously described subgenomic replicon containing the
P/M gene junction (pP/M) (Hardy et al., 1999) with each of
the five sequences that were the most different from the
prototype sequence: CA (pP/M-CA), CCA (pP/M-CCA),
CUA (pP/M-CUA), CCUA (pP/M-CCUA), and CUCUA
(pP/M-CUCUA) (Fig. 2A). The effects of these variations
were examined by transfection of the replicons into HEp-2
R.M. Moudy et al. / Virology 327 (2004) 121–133126cells and metabolic labeling of the synthesized RNA, as
described above.
The variant intergenic sequences did not significantly
alter termination at the P/M junction (Fig. 2B). Replicons
containing any of the intergenic regions examined had
readthrough amounts similar to that of pP/M (Fig. 2B).
Initiation was also unaffected by altering the P/M intergenic
region (Fig. 2C). Although not every variant P/M intergenic
region sequence found in the clinical isolates was tested in
this manner, these results seem to indicate that the P/Mgene junction can tolerate many different intergenic region
sequences without adversely affecting transcription.
Effect of deletion of the last nucleotide of the M/SH
intergenic region on transcription
The nucleotide of the intergenic region immediately
preceding the gene start sequence is an A in each HRSV
gene junction from the prototype strain A2 (Tables 2 and 3).
Previous studies have shown that changing this A to either a
C or U was detrimental to initiation at the downstream gene
start sequence (Kuo et al., 1997), but it is unknown whether
termination at the upstream gene end is also affected. The M/
SH intergenic region from isolate RSB89-6614 had a single
nucleotide deletion at this position, such that the nucleotide
preceding the SH gene start sequence was a U. To determine
if this deletion affected transcription, we constructed repli-
cons pM/SH-6614 and pM/SH-8106, which replaced the
prototype A2 strain intergenic region sequence in the previ-
ously described subgenomic replicon pM/SH-5U (Harmon et
al., 2001) with the intergenic region sequences from isolates
RSB89-6614 and RSB90-8106. The M/SH intergenic region
sequences of these isolates are identical except for the
deletion of the A immediately preceding the SH gene start
sequence in isolate RSB89-6614 (Fig. 3A). Replicon pM/
SH-5U was chosen rather than pM/SH, which contains a U6
tract in the M gene end sequence, as does the prototype A2
strain, because all of the isolates examined contained a U5
tract in their M gene end sequence (Moudy et al., 2003). The
effects of these variations on transcription events at the gene
junction were analyzed as described above.
Deletion of the A preceding the SH gene start substan-
tially decreased initiation, as shown by the loss of the
majority of the monocistronic mRNA2 product without a
significant effect on the other RNA species (Fig. 3A). TheFig. 2. Effect of variant intergenic regions on transcription at the P/M gene
junction. (A) Schematic of, and RNA species produced by, replicons pP/M,
pP/M-CA, pP/M-CCA, pP/M-CUA, pP/M-CCUA, and pP/M-CUCUA.
Each replicon contains 686 nucleotides surrounding and including the
HRSV A2 P/M gene junction. The variant intergenic region sequence
contained in each replicon is indicated, and the RNA species produced from
the replicons are shown. RNA species were analyzed as for Fig. 1A. CA:
pP/M-CA; CCA: pP/M-CCA; CUA: pP/M-CUA; CCUA: pP/M-CCUA;
CUCUA: pP/M-CUCUA. (B) Readthrough synthesis and termination
efficiencies from replicons pP/M, pP/M-CA, pP/M-CCA, pP/M-CUA, pP/
M-CCUA, and pP/M-CUCUA. Readthrough synthesis and percent
termination were determined as described in Materials and methods.
Shaded bars represent the mean of at least three separate experiments, with
error bars indicating the standard deviations. Dotted line indicates the level
of readthrough associated with the A2 sequence. CA: pP/M-CA; CCA: pP/
M-CCA; CUA: pP/M-CUA; CCUA: pP/M-CCUA; CUCUA: pP/M-
CUCUA. (C) Downstream initiation efficiency from replicons pP/M, pP/
M-CA, pP/M-CCA, pP/M-CUA, pP/M-CCUA, and pP/M-CUCUA.
Initiation efficiency was determined as described in Materials and methods.
Shaded bars represent the mean of at least three separate experiments, with
error bars indicating the standard deviations. Dotted line indicates the level
of initiation associated with the A2 sequence. CA: pP/M-CA; CCA: pP/M-
CCA; CUA: pP/M-CUA; CCUA: pP/M-CCUA; CUCUA: pP/M-CUCUA.
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approximately 40% in the replicons containing an A imme-
diately upstream of the gene start (pM/SH-5U and pM/SH-
8106) to just over 15% in pM/SH-6614 (Fig. 3C). In
addition, the A deletion slightly increased termination effi-
ciency at the M/SH gene junction, as measured by a decrease
in readthrough mRNA synthesis from 34% (pM/SH-8106
and pM/SH-5U) to 26% (pM/SH-6614); however, the dif-
ference in readthrough synthesis was small (Fig. 3B). This
suggests that the conserved A preceding the gene startsequence mainly affects initiation, as was described previ-
ously (Kuo et al., 1997).
Effect of the widely varied F/M2 intergenic region on
termination
The F/M2 intergenic region is one of the most variable,
with 10 different sequences found in the 14 isolates and
33% average variation per isolate (Table 3). To determine
whether any of the sequences found in the clinical isolates
affected termination, we constructed replicons containing
each of the unique sequences found at this gene junction,
including the A2 sequence (Fig. 4A). The effects of the
variant sequences were analyzed as described above, by
transfection of the appropriate plasmids into HEp-2 cells
and metabolic labeling of the RNA species produced.
Four of the isolate gene junction sequences had little
effect on termination at the F/M2 gene junction (pF/M2-721,
pF/M2-342, pF/M2-465, and pF/M2-8106) (Fig. 4B). How-
ever, two of the isolate replicons, pF/M2-131 and pF/M2-
1734, showed increased levels of readthrough transcription
as compared to pF/M2-A2. In addition, four isolate repli-
cons, pF/M2-893, pF/M2-6614, pF/M2-6190, and pF/M2-
1503, terminated more efficiently at the F gene end than the
A2 replicon. Of these, the most dramatic effect was found
with replicons pF/M2-893 and pF/M2-1503, which synthe-
sized 3-fold less readthrough than pF/M2-A2 (Fig. 4B).
When the entire F/M2 gene junctions of these isolates
were examined, we found that three contained either one
(RSG1503) or two (AL-180893 and AL-205342) additional
uridines in their F gene end U-tracts (Moudy et al., 2003).
Two of these replicons, pF/M2-1503 and pF/M2-893, ter-
minated more efficiently than A2, and since it has previ-
ously been shown that termination is more efficient at gene
ends containing longer U-tracts (Harmon and Wertz, 2002;
Harmon et al., 2001; Sutherland et al., 2001), it was possible
that the increased U-tract lengths in these replicons affected
their termination efficiencies. We examined this possibilityFig. 3. Effect of deletion of the nucleotide immediately preceding the gene
start sequence on transcription at the M/SH gene junction. (A) Schematic
of, and RNA species produced by replicons pM/SH-5U, pM/SH-6614, and
pM/SH-8106. Each replicon contains 602 nucleotides surrounding and
including the HRSV M/SH gene junction and has a single nucleotide
deletion in the U-tract of the M gene end. Replicons pM/SH-6614 and pM/
SH-8106 contain the intergenic regions from isolates RSB89-6614 and
RSB90-8106, respectively. RNA species were analyzed as for Fig. 1A. (B)
Readthrough synthesis and termination efficiencies from replicons pM/SH-
5U, pM/SH-6614, and pM/SH-8106. Readthrough synthesis and percent
termination were determined as described in Materials and methods.
Shaded bars represent the mean of at least three separate experiments, with
error bars indicating the standard deviations. Dotted line indicates the level
of readthrough associated with the A2 sequence. 6614: pM/SH-6614; 8106:
pM/SH-8106. (C) Downstream initiation efficiency of replicons pM/SH-
5U, pM/SH-6614, and pM/SH-8106. Initiation efficiency was determined
as described in Materials and methods. Shaded bars represent the mean of at
least three separate experiments, with error bars indicating the standard
deviations. Dotted line indicates the level of initiation associated with the
A2 sequence. 6614: pM/SH-6614; 8106: pM/SH-8106.
Fig. 4. Effect of variant intergenic regions on termination at the F/M2 gene
junction. (A) Schematic of replicons containing variant F/M2 gene
junctions. Replicons contain 130 nucleotides surrounding and including
the F/M2 gene junction from the HRSVA2 strain. Variant replicons contain
the entire gene junction (gene end, intergenic region, and gene start) from
clinical isolates. RNA species generated from the replicons were analyzed
as for Fig. 1A. (B) Readthrough synthesis and termination efficiencies from
variant F/M2 replicons. Readthrough synthesis and percent termination
were determined as described in Materials and methods. Shaded bars
represent the mean of at least three separate experiments, with error bars
indicating the standard deviations. Dotted line indicates the level of
readthrough associated with the A2 sequence. (C) Readthrough synthesis
and termination efficiencies from replicons containing the intergenic
regions from HRSV A2 and RSG-1503 with different U-tract lengths.
Replicons pF/M2-A2 and pF/M2-A2(5U) are identical except that pF/M2-
A2(5U) contains a U5-tract at the F gene end, rather than the U4-tract
contained in pF/M2-A2. Replicons pF/M2-1503 and pF/M2-1503(4U) are
identical except that pF/M2-1503(4U) contains U4-tract at the F gene end,
while pF/M2-1503 contains a U5-tract. Readthrough synthesis and percent
termination were determined as described in Materials and methods.
Shaded bars represent the mean of at least three separate experiments, with
error bars indicating the standard deviations. Dotted line indicates the level
of readthrough associated with the A2 sequence. A2: pF/M2-A2; A2(5U):
pF/M2-A2(5U); 1503: pF/M2-1503; 1503(4U): pF/M2-1503(4U).
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which were identical to replicons pF/M2-1503 and pF/
M2-A2, respectively, except that their F gene end U-tracts
were either shortened (pF/M2-1503(4U)) or lengthened (pF/
M2-A2(5U)) by one uridine. Termination at the F gene endsof these replicons was examined by transfection into HEp-2
cells and labeling of the RNA species produced, as de-
scribed above.
Lengthening the U-tract in the pF/M2-A2 F gene end
sequence decreased the amount of readthrough mRNA
synthesis (Fig. 4C), consistent with previous results showing
that gene end sequences with longer U-tracts terminate more
efficiently (Harmon and Wertz, 2002; Harmon et al., 2001).
However, shortening the U-tract in the pF/M2-1503 gene
end sequence from five uridines to four (pF/M2-1503(4U))
had no measurable effect on transcription (Fig. 4C). These
results suggest that the variant F/M2 intergenic region in
isolate RSG1503, rather than its longer F gene end U-tract,
is responsible for its increased termination efficiency.Discussion
It has been determined previously that sequences present
at the gene junctions of HRSV are critical for termination
and initiation of transcription. The gene end sequences are
primarily responsible for directing efficient termination,
while the gene start sequences direct initiation. If the
sequence integrity of either of these elements is disrupted,
normal transcription cannot occur (Cartee et al., 2003;
Hardy et al., 1999; Harmon and Wertz, 2002; Harmon et
al., 2001; Kuo et al., 1996a, 1996b, 1997; Moudy et al.,
2003; Sutherland et al., 2001).
Although the roles of the gene end and start sequences
are well established, the role of the intergenic region in
HRSV transcriptional control is not well defined. The length
of the intergenic region can be increased to at least 160
nucleotides at an artificial M/G gene junction (in a virus
lacking the SH gene sequence) without major effects on
transcription (Bukreyev et al., 2000), although viruses with
intergenic regions of 100 or more nucleotides were delayed
in their replication as compared to those with shorter inter-
genic regions. Studies by Kuo et al. (1996a) using a reporter
gene replicon system found no discernable effect on termi-
nation when the N/P intergenic region was replaced with
each of the naturally occurring HRSV intergenic regions,
but when the intergenic region was deleted or replaced with
a G/C-rich sequence, termination was inhibited by approx-
imately 30%. The first nucleotide of the intergenic region
was found to affect termination when the gene end
contained a U4-tract (Harmon and Wertz, 2002; Sutherland
et al., 2001), while the conserved last nucleotide was shown
to be involved in initiation (Kuo et al., 1997).
We determined the intergenic region sequences from 14
serogroup A clinical isolates and found substantial variation
from the prototype A2 strain. The work described here
examines whether these changes could have biological sig-
nificance. The extent of variability differed among the nine
different intergenic regions and did not relate to position in
the HRSV genome or length of the intergenic region se-
quence (Tables 2 and 3). The lengths of each of the intergenic
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though small changes in length were found, and these were
more common in the longer intergenic regions SH/G, G/F,
and F/M2. The notable exception was the P/M gene junction,
at which all but one of the isolates contained a deletion of at
least four of the nine nucleotides found at this intergenic
region in the A2 strain.
Not surprisingly, the M2/L overlap was well conserved,
since a change in this region has the potential to change the
L protein sequence in addition to any potential alteration to
transcriptional termination and/or initiation efficiency. Sin-
gle nucleotide changes were found in four of the 14 isolates
sequenced, for a total of two changes out of 46 nucleotides,
neither of which were coding changes.
In general, isolates belonging to the genotype GA1
contained intergenic region sequences with the highest
identity to A2 intergenic region sequences. Isolates belong-
ing to genotypes GA3 and GA5 contained intergenic
regions that generally had lower identity to the A2 sequen-
ces. This was expected, since in phylogenetic analyses
based on sequences from the G open reading frame
(ORF), genotype GA1 is most closely related to the A2
strain, while genotypes GA3 and GA5 are less related to A2
(Peret et al., 2000; Sullender, 2000). Isolate RSG1503 was
unusual in that although its G ORF and gene end sequences
are more closely related to A2 and genotype GA1 isolates
(Cane and Pringle, 1995; Moudy et al., 2003), its intergenic
region sequences were generally more similar to sequences
from the GA3 and GA5 isolates.
When several of the intergenic sequences from the
isolates were examined in the context of subgenomic
replicons for their possible effects on transcriptional control,
it was found that although extensive changes in intergenic
region sequence at certain gene junctions had no measurable
effects on transcription, seemingly minor variations in the
intergenic region sequence had significant effects at other
gene junctions. The effect of deleting up to two thirds of the
P/M intergenic region sequence was negligible, as replicons
containing these variant intergenic region sequences termi-
nated and initiated as well as one containing the authentic
A2 gene junction. At the F/M2 gene junction, certain isolate
sequences had little effect on transcription as compared to
the A2 sequence, while other very similar sequences either
decreased or increased the amount of readthrough observed.
Thus, it does not appear that the amount of variation present
in an isolate’s intergenic region sequence is an accurate
predictor of the potential effect of that sequence on tran-
scriptional control at that gene junction.
Since all of the isolates examined in this study were
derived from children with severe HRSV infections, it is
unlikely that we would have discovered intergenic region
sequences that severely compromise viral gene expression. In
fact, out of the variant sequences tested in our replicon
system, only the M/SH intergenic region from RSB89-6614
had a significant detrimental effect on transcription, with
deletion of the last A of the intergenic region leading todecreased initiation at the SH gene start. In a viral context,
this isolate would be expected to express less SH mRNA and
protein than isolates containing an A immediately upstream
of the SH gene start sequence. The SH gene can be deleted
from the HRSV genome without significant effects on viral
replication in cell culture, the lungs of mice and cotton rats, or
the upper respiratory tract of chimpanzees (Bukreyev et al.,
1997; Jin et al., 2000; Whitehead et al., 1999). However,
replication of a DSH virus was moderately attenuated in the
lower respiratory tract of chimpanzees (Whitehead et al.,
1999). It seems surprising that RSB89-6614would contain an
intergenic region that could lower its replication ability due to
down-regulation of SH expression since it was isolated from
a hospitalized patient, although it is possible that decreased
amounts of SH protein havemuch less of an attenuating effect
than complete loss of SH protein expression. An alternative
explanation is that the detrimental sequence arose during
virus propagation in cell culture and does not represent theM/
SH intergenic region sequence present in the original isolate,
or that the sequence was present in the original isolate
quasispecies in small amounts and has become the dominant
sequence during multiple passages in cell culture.
A common feature of the HRSV intergenic regions is that
they are generally A/U-rich, with the notable exception of
the P/M intergenic region. While the variant sequences
found at the other intergenic regions had similar base
composition to the A2 sequence, at the P/M gene junction,
the isolate sequences were usually more A/U-rich than A2.
Previous studies by Kuo et al. (1996a) have shown that
replacing an authentic HRSV intergenic region with non-
viral sequence that is G/C-rich decreased synthesis of the
downstream gene product. In contrast, we found that replac-
ing the A2 P/M intergenic region with shorter sequences
that were more A/U-rich did not lead to increased initiation
at the M gene start. Several factors could account for this
apparent discrepancy. Our system used authentic HRSV P
and M sequences upstream and downstream from the P/M
gene junction, whereas the previous study used reporter
genes such that the only HRSV sequence was the gene
junction. Also, the previous study paired the N gene end
sequence with the G/C-rich intergenic region, while we used
the P gene end sequence. It is possible that the minor
differences in sequence between the N and P gene ends
could lead to the different results.
Studies of VSIV have shown that when the gene end was
separated from the gene start by an extended intergenic region
of up to 88 nucleotides, a U-tract just upstream of the gene
start sequence was required for efficient initiation (Hinzman
et al., 2002). In contrast to VSIV, which has a highly
conserved intergenic region of two nucleotides separating
the gene end from the gene start, it seems unlikely that the
gene end U-tracts of HRSV would play a role in downstream
initiation, since they can be 52 nucleotides upstream. How-
ever, it is possible that some feature of the intergenic regions
can compensate for this in cases where the gene end U-tract is
separated from the gene start by a long intergenic region. In
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regions upstream of the gene start sequence, which are
conserved in the variant sequences found in the clinical
isolates. It would be interesting to examine whether these
intergenic U-tracts are involved in downstream initiation.
It has been shown with other negative-strand RNA
viruses that changes in intergenic region sequences can
affect both termination of the upstream gene and initiation
of the downstream gene (Barr et al., 1997; Bukreyev et al.,
2000; Finke et al., 2000; Harmon and Wertz, 2002; Hinz-
man et al., 2002; Kuo et al., 1996a; Parks et al., 2001a,
2001b; Rassa and Parks, 1998, 1999; Rassa et al., 2000;
Stillman and Whitt, 1997, 1998). Mutation of the nucleo-
tides in the VSIV intergenic region, normally 3V. . .(g/
c)A. . .5V, altered the relative abundance of the upstream,
downstream, and readthrough mRNA species (Barr et al.,
1997; Stillman and Whitt, 1997, 1998). VSIV natural
isolates tend to contain intergenic region changes that do
not greatly alter transcription termination or initiation
(Rodriguez et al., 2002). In HRSV and SV-5, the first
nucleotide of the intergenic region affects termination of
the upstream gene end when the gene end has a U4-tract,
but not a U6-tract (Harmon and Wertz, 2002; Rassa and
Parks, 1999). SV-5 intergenic regions are also involved in
efficient downstream initiation and can lead to viral growth
defects in cell culture (Parks et al., 2001b; Rassa and
Parks, 1999; Rassa et al., 2000). The intergenic regions of
RaV contribute to differential transcriptional attenuation by
modulating downstream initiation (Finke et al., 2000).
While it appears that the HRSV intergenic regions play
less of a role in transcriptional regulation than many of
their counterparts in other NNS viruses, our results indicate
that these intergenic region sequences can contribute to
both termination and initiation of transcription.
In conclusion, we have analyzed the degree of variation
in the intergenic regions of a group of HRSV clinical isolates
from the US and UK. We found that the amount of variation
observed in a particular intergenic region did not correlate
with its length or position in the genome. Many of these
variant intergenic regions, including those that are very
different from the prototype A2 sequence, had little effect
of transcription, while other changes at certain gene junc-
tions significantly affected transcription initiation and/or
termination. These results indicate that although the inter-
genic regions do not regulate transcription to the same extent
as the gene start and gene end sequences, they can influence
transcriptional control at the HRSV gene junctions.Materials and methods
Viruses and cells
HRSV clinical isolates obtained from Children’s Hospital
of Alabama (Birmingham) and Birmingham, Glasgow, and
Newcastle, United Kingdom were propagated in HEp-2cells. Fourteen subgroup A viruses were used in these
studies, six from Alabama (AL-180893, AL-180081, AL-
195131, AL-194465, AL-203721, AL-205342) (Coggins et
al., 1998; Sullender, 2000) and eight from the United
Kingdom (RSB89-1734, RSB89-6614, RSB89-6190,
RSB89-6256, RSB89-5857, RSB90-8106, RSG1503,
RSS2) (Cane and Pringle, 1991, 1995; Tolley et al., 1996).
RT-PCR and nucleotide sequencing
HEp-2 cells were infected at an MOI of 0.5 in minimal
essential medium (MEM) supplemented with 2% heat-
inactivated fetal bovine serum (FBS) and incubated at 37
jC. Total RNA was harvested from cell lysates using the
RNeasy mini kit (Qiagen) according to the manufacturer’s
instructions. RT-PCR was performed using a one-step RT-
PCR kit (Qiagen) with primers flanking each internal gene
junction (Hardy et al., 1999). The cDNA products were
purified by DNA extraction (Qiagen) following agarose gel
electrophoresis. Automated sequencing was performed by
fluorescent dye-termination on ABI Model 377 and 373A
DNA sequencers (DNA Sequencing Facility, Center for
AIDS Research, UAB).
Variability among the isolates’ intergenic regions was
analyzed in three ways. First, the number of isolates contain-
ing sequence variation was examined for each intergenic
region. Second, the number of unique sequences found for
each intergenic region was examined. Finally, the nucleotide
sequence of each intergenic region was compared to the
prototype A2 strain to give the percent identity for each
region in each isolate. This was done by first aligning the
sequences using the GCG Wisconsin Package 10.3
(Accelrys) and then dividing the number of positions in an
isolate sequence that were identical to the A2 sequence by the
total number of positions in the alignment, including any gaps
that were introduced for optimization of the alignment. This
allowed comparison of the amount of variation in the indi-
vidual sequences without the confounding variable of differ-
ing intergenic region sequence lengths among the isolates.
Plasmid construction
The plasmids pN/P, pP/M, and pM/SH, encoding sub-
genomic RNA replicons, were previously constructed and
contain the N/P, P/M, and M/SH gene junctions, respective-
ly, from the prototype A2 strain of HRSV (Hardy et al.,
1999). Plasmid pN/P contains nucleotides 2177 to 2556, pP/
M contains nucleotides 2963 to 3649, and pM/SH contains
nucleotides 3895 to 4497.
Plasmid pN/P-CA is identical to pN/P except that the N/
P intergenic region has been changed to the dinucleotide
CA and was constructed using QuikChange mutagenesis
(Strategene).
Plasmids pP/M-CA, pP/M-CCA, pP/M-CUA, pP/M-
CCUA, and pP/M-CUCUA, encoding the intergenic regions
from isolates RSB89-1503 (CA), AL-195131, AL-194465
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RSB89-6614, RSB89-6256, RSB89-5857, RSS2 (CUA),
RSB89-6190 (CCUA), and RSB90-8106 (CUCUA), respec-
tively, were constructed from plasmid pP/M using Quik-
Change mutagenesis.
The previously constructed plasmid pM/SH-5U is iden-
tical to plasmid pM/SH, but encodes a mutated M gene
end sequence in which the U-tract has been shortened to
five nucleotides (Harmon et al., 2001). Plasmids pM/SH-
6614 and pM/SH 8106, encoding the entire gene junction
(M gene end, intergenic region, and SH gene start) from
isolates RSB89-6614 and RSB90-8106, respectively, were
constructed from plasmid pM/SH-5U using QuikChange
mutagenesis.
Plasmids containing the F/M2 gene junction sequences
from each clinical isolate, as well as the prototype A2 strain,
were constructed from cDNA corresponding to nucleotides
7520 to 7650 in the A2 sequence from each virus. Since
isolates AL-180081 and AL-203721 contained identical F/
M2 gene junction sequences, as did isolates RSB90-8106,
RSB89-6256, and RSB89-5857 and isolates RSB89-6614
and RSS2, we constructed one plasmid per unique se-
quence. PCR was performed using Pfu polymerase (Stra-
tagene) with an upstream primer containing an EcoRI site
and a downstream primer containing a BglII site. The PCR
products were digested with EcoRI and BglII and subcloned
into the unique MfeI and BglII sites in the previously
described plasmid pWT (Hardy and Wertz, 1998) to create
the following plasmids: pF/M2-A2, pF/M2-893, pF/M2-
081, pF/M2-342, pF/M2-151, pF/M2-465, pF/M2-1734,
pF/M2-6614, pF/M2-6190, pF/M2-8106, and pF/M2-1503.
Plasmids pF/M2-1503(4U) and pF/M2-A2(5U) were con-
structed from plasmids pF/M2-1503 and pF/M2-A2, respec-
tively, using QuikChange mutagenesis. The sequences of all
of the above plasmids were confirmed by automated se-
quencing and were identical except for the intended varia-
tions in their gene junction sequences.
Transfection and RNA analysis
HRSV RNA synthesis was analyzed in cells essentially
as previously described (Hardy and Wertz, 1998; Moudy et
al., 2003). Briefly, HEp-2 cells were grown in a 60-mm
culture dish and infected with MVA-T7 at an MOI of 10
pfu per cell. MVA-T7 is a recombinant vaccinia virus that
expresses T7 RNA polymerase and was kindly provided
by B. Moss. Approximately 1 h after MVA-T7 infection,
cells were transfected with plasmids encoding a subge-
nomic replicon (4 Ag) and four HRSV proteins—pN (1.5
Ag), pP (0.75 Ag), pPol1049N (0.4 Ag), and pM2-1 (0.2
Ag)—using 20 Al of Lipofectin (Life Technologies). Tran-
scription from these plasmids was driven by T7 promoters.
Approximately 16 h post-transfection, the cells were
exposed to [3H]-uridine (33 ACi/ml, Moravek Biochemicals)
in the presence of actinomycin D (10 Ag/ml) and cytosine
arabinoside (50 Ag/ml) for 6 h. RNAwas purified from cellsusing a phenol/chloroform/isoamyl alcohol extraction meth-
od, as described previously (Hardy and Wertz, 1998; Hardy
et al., 1999). [3H]-labeled RNAs were analyzed by 1.75%
agarose/6 M urea/25 mM citrate gel electrophoresis and
detected by fluorography.
RNA quantitation
The RNA species produced from the pN/P, pP/M, and
pM/SH replicons have been identified previously (Hardy et
al., 1999). These species are: the positive and negative
sense replication products (rep.); the mRNA produced
from the first gene (mRNA1); the mRNA produced from
the second gene (mRNA2); the readthrough product pro-
duced when the polymerase fails to terminate at the end of
the first gene (r/t 1–2). The products produced from the
pF/M2-A2 replicon were identified by RNase H digestion.
Termination was assessed by calculating either the
percent termination, which measured the amount of mono-
cistronic message transcribed by a polymerase that initiated
at the first gene start sequence and terminated at the first
gene end sequence, or the percent readthrough, which
measured the amount of dicistronic readthrough RNA
generated when the polymerase initiated at the first gene
start sequence, but failed to terminate at the first gene end
sequence, readthrough the gene junction, and terminated at
the second gene end sequence. To determine the percent
termination and percent readthrough at the first gene end
in the various replicons, mRNA species that initiate at the
beginning of the first gene (mRNA1, r/t 1–2) were
quantitated by densitometry using a Howtek Scanmaster
3 and PDI Quantity One software, as recommended by the
manufacturer. Percent termination was calculated using the
following formula: % termination = 100  [mRNA1/
(mRNA1 + r/t 1–2)]. Percent readthrough was calculated
using the formula % readthrough = 100  100 
[mRNA1/(mRNA1 + r/t 1–2)], which was equivalent to
(100  %termination). To obtain molar equivalents of
RNA, the optical density for each RNA species was
adjusted for the number of uridines incorporated into that
RNA, and these molar amounts were used in calculating
percent termination and percent readthrough.
Initiation was assessed by examining the initiation effi-
ciency, defined as how often a polymerase that terminates
transcription at the upstream gene end continues on to
initiate transcription at the next gene start. To determine
the initiation efficiency, the molar amounts of mRNA1 and
mRNA2 were quantitated as described above. The levels of
initiation were calculated using the formula % initiation =
100 – 100  (mRNA2/mRNA1).Acknowledgments
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